Gill David N

Evolus, Inc. ยท Director

Gill David N is listed in public filings as director. This Gill David N insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Evolus, Inc. (EOLS), and Y-mAbs Therapeutics, Inc. (YMAB). Investors use Gill David N's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Evolus, Inc.EOLS--86.9k sharesGrant / ExerciseFeb 17, 2026Disclosure amount unavailable45.6k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Y-mAbs Therapeutics, Inc.YMAB$011k sharesOtherSep 16, 2025$535.4K11k shares$48.67--
Y-mAbs Therapeutics, Inc.YMAB$011k sharesOtherSep 16, 2025$412.8K11k shares$37.53--
Y-mAbs Therapeutics, Inc.YMAB$016k sharesOtherSep 16, 2025$343.2K16k shares$21.45--
Y-mAbs Therapeutics, Inc.YMAB$024k sharesOtherSep 16, 2025$267.8K24k shares$11.16--
Y-mAbs Therapeutics, Inc.YMAB$016k sharesOtherSep 16, 2025$266.2K16k shares$16.64--
Y-mAbs Therapeutics, Inc.YMAB--25.1k sharesOtherSep 16, 2025Disclosure amount unavailable25.1k shares----
Y-mAbs Therapeutics, Inc.YMAB$014.5k sharesOtherSep 16, 2025$174.7K14.5k shares$12.01--
Y-mAbs Therapeutics, Inc.YMAB$033.5k sharesOtherSep 16, 2025$150.9K33.5k shares$4.51--
Y-mAbs Therapeutics, Inc.YMAB$014k sharesOtherSep 16, 2025$113.4K14k shares$8.13--
Y-mAbs Therapeutics, Inc.YMAB$05.8k sharesOtherSep 16, 2025$50.1K5.8k shares$8.60--
Y-mAbs Therapeutics, Inc.YMAB--30.9k sharesGrant / ExerciseJun 30, 2025Disclosure amount unavailable25.1k shares----
Y-mAbs Therapeutics, Inc.YMAB$151k33.5k sharesGrant / ExerciseJun 30, 2025$150.9K33.5k shares$4.51--
Evolus, Inc.EOLS--41.3k sharesGrant / ExerciseMar 7, 2025Disclosure amount unavailable7.4k shares----
Evolus, Inc.EOLS$151k11.1k sharesGrant / ExerciseMar 7, 2025$151.4K11.1k shares$13.58--
Y-mAbs Therapeutics, Inc.YMAB--5.8k sharesGrant / ExerciseJun 11, 2024Disclosure amount unavailable3.5k shares----
Y-mAbs Therapeutics, Inc.YMAB$175k14.5k sharesGrant / ExerciseJun 11, 2024$174.7K14.5k shares$12.01--
Gill David N | TradingNote